vimarsana.com

Latest Breaking News On - Nasdaq hcwb - Page 1 : vimarsana.com

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Update

HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Approximately 0.1% of the shares of the company are […]

Biologics-company-profile
Biologics-inc
Nasdaq
Hcw-biologics-inc
Blackrock-inc
Avantax-planning-partners-inc
Hightower-advisors
Vanguard-group-inc
Get-free-report
Planning-partners
Tower-advisors

Masonic Cancer Center, University of Minnesota to Present

HCW Biologics Inc. (NASDAQ:HCWB) Sees Large Drop in Short Interest

HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 21,400 shares, a decrease of 14.4% from the August 15th total of 25,000 shares. Currently, 0.1% of the company’s stock are short sold. […]

Blackrock-inc
Hcw-biologics-inc
Vanguard-group-inc
Hightower-advisors
Biologics-inc
Nasdaq
Get-free-report
Tower-advisors
Hcw-biologics
Nasdaq-hcwb
Hcwb

Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Drops By 13.4%

HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) saw a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 23,200 shares, a drop of 13.4% from the July 15th total of 26,800 shares. Approximately 0.1% of the company’s shares are short sold. Based on an […]

Rebecca-byam
Biologics-company-profile
Nasdaq
Biologics-inc
Vanguard-group-inc
Ef-hutton-acquisition-co
Hcw-biologics-inc
Blackrock-inc
Hightower-advisors
Securities-exchange-commission
Get-free-report
Stock-down

HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Up 86.9% in June

HCW Biologics Inc. (NASDAQ:HCWB – Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 24,300 shares, a growth of 86.9% from the May 31st total of 13,000 shares. Currently, 0.1% of the company’s shares are short sold. Based […]

Rebecca-byam
Nasdaq
Ef-hutton-acquisition-co
Blackrock-inc
Hcw-biologics-inc
Biologics-inc
Vanguard-group-inc
Biologics-company-profile
Hightower-advisors
Free-report
Stock-down
Tower-advisors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.